AU2002330239B2 - Method for treating retroviral infections - Google Patents
Method for treating retroviral infections Download PDFInfo
- Publication number
- AU2002330239B2 AU2002330239B2 AU2002330239A AU2002330239A AU2002330239B2 AU 2002330239 B2 AU2002330239 B2 AU 2002330239B2 AU 2002330239 A AU2002330239 A AU 2002330239A AU 2002330239 A AU2002330239 A AU 2002330239A AU 2002330239 B2 AU2002330239 B2 AU 2002330239B2
- Authority
- AU
- Australia
- Prior art keywords
- oxide
- pyridine
- dimethylphenyl
- sulfonyl
- methylsulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/021,453 US7064139B2 (en) | 2001-10-29 | 2001-10-29 | Method for treating retroviral infections |
| US10/021,453 | 2001-10-29 | ||
| PCT/US2002/031836 WO2003037311A2 (en) | 2001-10-29 | 2002-10-03 | Method for treating retroviral infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002330239A1 AU2002330239A1 (en) | 2003-07-10 |
| AU2002330239B2 true AU2002330239B2 (en) | 2008-06-26 |
Family
ID=21804307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002330239A Expired - Fee Related AU2002330239B2 (en) | 2001-10-29 | 2002-10-03 | Method for treating retroviral infections |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US7064139B2 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2005515169A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1602194A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2002330239B2 (cg-RX-API-DMAC10.html) |
| BR (1) | BR0213742A (cg-RX-API-DMAC10.html) |
| CA (1) | CA2464303A1 (cg-RX-API-DMAC10.html) |
| MX (1) | MXPA04004058A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2003037311A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1701940B1 (en) * | 2003-12-23 | 2008-05-28 | H.Lundbeck A/S | 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| AR052308A1 (es) * | 2004-07-16 | 2007-03-14 | Lundbeck & Co As H | Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto |
| US7629473B2 (en) * | 2005-06-17 | 2009-12-08 | H. Lundbeck A/S | 2-(1H-indolylsulfanyl)-aryl amine derivatives |
| AR054393A1 (es) * | 2005-06-17 | 2007-06-20 | Lundbeck & Co As H | Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos. |
| JP2010512333A (ja) * | 2006-12-07 | 2010-04-22 | ヘルシン ヘルスケア ソシエテ アノニム | 塩酸パロノセトロンの結晶及び非晶質形 |
| CN106674099A (zh) * | 2016-12-22 | 2017-05-17 | 江苏燎原环保科技股份有限公司 | 一种二[2‑(n‑氧化物‑吡啶基‑2‑硫基)乙基]胺的制备方法 |
| CN106674100A (zh) * | 2016-12-22 | 2017-05-17 | 江苏燎原环保科技股份有限公司 | 一种三[2‑(n‑氧化物‑吡啶基‑2‑硫基)乙基]胺的制备方法 |
| CN108956809B (zh) * | 2018-06-04 | 2021-03-23 | 四川科伦药物研究院有限公司 | 一种检测1-(1-氯乙基)-2,3-二甲苯有关物质的方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2039218A (en) * | 1978-11-30 | 1980-08-06 | Wyeth John & Brother Ltd | Pharmaceutical Compositions |
| WO1999032450A1 (en) * | 1997-12-22 | 1999-07-01 | Pharmacia & Upjohn Company | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| JP2000302760A (ja) * | 1999-02-17 | 2000-10-31 | Hokuriku Seiyaku Co Ltd | 2−メルカプトキノリン誘導体 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1268772A (en) * | 1968-03-15 | 1972-03-29 | Glaxo Lab Ltd | NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME |
| US3960542A (en) * | 1975-03-17 | 1976-06-01 | Uniroyal Inc. | Herbicidal 2-sulfinyl and 2-sulfonyl pyridine N-oxide derivatives |
| JPS52125170A (en) * | 1976-04-12 | 1977-10-20 | Yoshitomi Pharmaceut Ind Ltd | Pyridine derivatives |
| US4371537A (en) * | 1981-08-13 | 1983-02-01 | The Dow Chemical Company | Sulfur-substituted phenoxypyridines having antiviral activity |
| US4616087A (en) * | 1982-05-21 | 1986-10-07 | The Dow Chemical Company | 2,5-bis alkyl sulfonyl and 2,5-bis alkyl thio substituted-pyridines |
| US5268389A (en) * | 1989-10-16 | 1993-12-07 | Uniroyal Chemical Company, Inc. | Thiocarboxylate ester compounds compositions containing the same |
| NZ240313A (en) * | 1990-10-22 | 1994-04-27 | Res Corp Technologies Inc | Anti-retrovirus compositions containing aryl and heteroaryl derivatives |
| WO1995029897A1 (en) * | 1994-04-29 | 1995-11-09 | G.D. Searle & Co. | METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS |
| FR2737496B1 (fr) * | 1995-07-31 | 1997-12-19 | Centre Nat Rech Scient | 4-aryl-thio-pyridin-2(1h)-ones, medicaments les contenant et leurs utilisations dans le traitement de maladies liees aux vih 1 et 2 |
| US5770613A (en) * | 1995-09-29 | 1998-06-23 | Geron Corporation | Telomerase inhibitors |
| US5696151A (en) * | 1995-11-30 | 1997-12-09 | Uniroyal Chemical Company, Inc. | Compounds useful for the inhibition of the replication of HIV-1 and HIV-1 mutants |
| WO1998017267A1 (en) * | 1996-10-23 | 1998-04-30 | Zymogenetics, Inc. | Compositions and methods for treating bone deficit conditions |
| IL146105A (en) * | 1999-04-23 | 2005-09-25 | Tadeda Pharmaceutical Company | 5-pyridyl-1, 3-azole compounds, process for producing the same and use therefor |
| US6316472B1 (en) * | 1999-05-13 | 2001-11-13 | Merck Frosst Canada & Co. | Heterosubstituted pyridine derivatives as PDE 4 inhibitors |
| WO2001010842A2 (en) * | 1999-08-04 | 2001-02-15 | Millennium Pharmaceuticals, Inc. | Melanocortin-4 receptor binding compounds and methods of use thereof |
| US6498254B1 (en) * | 2001-10-29 | 2002-12-24 | Uniroyal Chemical Company, Inc. | Antiretroviral compounds and compositions |
-
2001
- 2001-10-29 US US10/021,453 patent/US7064139B2/en not_active Expired - Fee Related
-
2002
- 2002-10-03 CN CNA028216873A patent/CN1602194A/zh active Pending
- 2002-10-03 AU AU2002330239A patent/AU2002330239B2/en not_active Expired - Fee Related
- 2002-10-03 JP JP2003539655A patent/JP2005515169A/ja active Pending
- 2002-10-03 CA CA002464303A patent/CA2464303A1/en not_active Abandoned
- 2002-10-03 BR BRPI0213742-9A patent/BR0213742A/pt not_active IP Right Cessation
- 2002-10-03 MX MXPA04004058A patent/MXPA04004058A/es not_active Application Discontinuation
- 2002-10-03 WO PCT/US2002/031836 patent/WO2003037311A2/en not_active Ceased
-
2003
- 2003-12-19 US US10/740,869 patent/US20040204451A1/en not_active Abandoned
- 2003-12-19 US US10/740,696 patent/US20040132778A1/en not_active Abandoned
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2039218A (en) * | 1978-11-30 | 1980-08-06 | Wyeth John & Brother Ltd | Pharmaceutical Compositions |
| WO1999032450A1 (en) * | 1997-12-22 | 1999-07-01 | Pharmacia & Upjohn Company | 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents |
| JP2000302760A (ja) * | 1999-02-17 | 2000-10-31 | Hokuriku Seiyaku Co Ltd | 2−メルカプトキノリン誘導体 |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003037311A2 (en) | 2003-05-08 |
| US20040204451A1 (en) | 2004-10-14 |
| CA2464303A1 (en) | 2003-05-08 |
| CN1602194A (zh) | 2005-03-30 |
| WO2003037311A3 (en) | 2003-10-16 |
| MXPA04004058A (es) | 2004-09-06 |
| BR0213742A (pt) | 2006-05-23 |
| US20030139445A1 (en) | 2003-07-24 |
| US7064139B2 (en) | 2006-06-20 |
| US20040132778A1 (en) | 2004-07-08 |
| JP2005515169A (ja) | 2005-05-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6727364B2 (en) | Triazole compounds useful in treating diseases associated with unwanted cytokine activity | |
| AU2011227398B2 (en) | Modulators of Hec1 activity and methods therefor | |
| KR20050084112A (ko) | 비-뉴클레오사이드 역전사효소 억제제 | |
| CA2262252C (en) | Method of treating heart failure | |
| US20100240716A1 (en) | Thiadiazoline derivative | |
| NZ206614A (en) | Dihydropyridine derivatives and pharmaceutical compositions | |
| US7064139B2 (en) | Method for treating retroviral infections | |
| AU2002330239A1 (en) | Method for treating retroviral infections | |
| EP0554377A1 (en) | Aryl and heteroaryl compounds having anti-retrovirus activity | |
| EP2351739A1 (en) | The 2-(4-substituted phenylamino) polysubstituted pyridine compounds as the inhibitors of non-nucleoside hiv reverse transcriptase, praparation methods and uses thereof | |
| CZ20032677A3 (cs) | Derivát fenylheterocyklyletheru jako inhibitor reabsorpce serotoninu, jeho použití a farmaceutický prostředek, který ho obsahuje | |
| US6498254B1 (en) | Antiretroviral compounds and compositions | |
| EP4479399A1 (en) | Adenosine ligands for the treatment of neurological disorders | |
| JP6231195B2 (ja) | スルホニルインドール誘導体およびその製造方法 | |
| AU2005219689A1 (en) | Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein | |
| ATE358128T1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
| DK171988B1 (da) | Kvaternære 8-(alkyldithio)-1-(2-pyrimidyl)quinoliniumsalte | |
| NO861756L (no) | Fremgangsmaate ved fremstilling av dihydropyridinderivater. | |
| CS244145B2 (en) | Method of 4,5,6,7-tetrahydrothiazolo-(5,4-c)pyridine derivatives production | |
| EP0330329B1 (en) | Antiulcer pyrimidine derivatives | |
| EP3319940B1 (en) | New indole compounds having antiprotozoal activity and its use as well as methods for producing the same | |
| US5182387A (en) | Bis-dibenzoazepine compounds | |
| AU2002363217A1 (en) | Antiretroviral pyridine and quinoline derivatives | |
| WO2020027905A2 (en) | Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents | |
| WO2016056606A1 (ja) | ベンゾイソチアゾロピリミジン誘導体またはその塩、およびウイルス感染阻害剤ならびに医薬品 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |